Associations Between Preconception Glycemia and Preterm Birth: The Potential Role of Health Care Access and

Erin Delker1,2, Gladys A Ramos3, Gretchen Bandoli2

  • 1Department of Public Health, San Diego State University, Joint Doctoral Program in Public Health, San Diego, California, USA.

Insights

Preconception diabetes and prediabetes significantly increase preterm birth risk. Healthcare access and utilization further modify these risks, highlighting the need for improved preconception care.

Area of Science:

  • Reproductive Health
  • Endocrinology
  • Public Health

Background:

  • Preconception diabetes is linked to adverse birth outcomes.
  • The impact of elevated blood glucose below diabetes thresholds on birth outcomes is less understood.
  • Healthcare access may influence the relationship between maternal glycemic status and preterm birth.

Purpose of the Study:

  • To assess the association between preconception diabetes, prediabetes, and hemoglobin A1c (HbA1c) levels with preterm birth risk.
  • To investigate whether healthcare access and utilization modify these associations.

Main Methods:

  • Utilized data from the US prospective Add Health cohort study.
  • Measured glucose and HbA1c in Wave IV (ages 24-32).
  • Collected preterm birth data in Wave V (ages 32-42) from women with live births; N=1989.

Main Results:

  • Preterm birth prevalence was 13%.
  • Diabetes (6.9%) and prediabetes (23.7%) were associated with significantly higher preterm birth risks (OR 2.1 and 1.3, respectively) compared to normoglycemia.
  • Increased preterm birth risk emerged at HbA1c levels of 5.7% and was amplified by unstable healthcare coverage or emergency room reliance.

Conclusions:

  • Confirms strong links between preconception diabetes and preterm birth.
  • Identifies prediabetes as an independent risk factor for preterm birth.
  • Suggests interventions to improve preconception healthcare access and utilization are crucial, particularly for women with elevated HbA1c.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
309
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
250
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K